Rx Name [ROSUVASTATIN, 240608]

Rx Name	APO-ROSUVASTATIN 40MG TAB (APO/COL)
Active Ingredient	ROSUVASTATIN
Therapeutic Code	240608
Therapeutic Class	HMG-CoA REDUCTASE INHIBITORS
Indications	Primary hypercholesterolaemia (type IIa including heterozygous familial hypercholesterolaemia)’ mixed dyslipidaemia (type Iib), or homozygous familial hypercholesterolaemia in patients who have not responded adequately to diet and other appropriate m
Caution	Headache, asthenia, upper respiratory infections, gastrointestinal symptoms, and myalgia have been reported; myopathy has occurred rarely .
Dose Range	Adult: 5-20mg once daily . Doses may be titrated to 40mg per day in those who do not meet their lipid lowering goals on 20mg per day. Doses to be increased at intervals of at least 4 weeks. See BDS supply protocols pg. 6.
Drug Interactions
Pregnancy	Statins should be avoided in pregnancy (discontinue 3 months before attempting to conceive) as congenital anomalies have been reported and the decreased synthesis of cholesterol possibly affects fetal development.
Breast Feeding	Avoid use of rosuvastatin in lactating women.
Drug Note